These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20121554)

  • 41. Methotrexate-induced acute toxic leukoencephalopathy.
    Salkade PR; Lim TA
    J Cancer Res Ther; 2012; 8(2):292-6. PubMed ID: 22842379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebral sinus venous thrombosis in a subject with thyrotoxicosis and MTHFR gene polymorphism.
    Strada L; Gandolfo C; Del Sette M
    Neurol Sci; 2008 Oct; 29(5):343-5. PubMed ID: 18941937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent dural venous sinus thrombosis in a 20-year-old man: nature or nurture?
    Marrin C; Lewis S
    Br J Haematol; 2009 May; 145(4):439. PubMed ID: 19055660
    [No Abstract]   [Full Text] [Related]  

  • 44. [A case of acute lymphoblastic leukemia of MTHFR C677T gene positive with methotrexate hypersensitivity was successfully rescued by hemodialysis].
    Ren LW; Wu T; Xue F; Liu WH; Mao DF; Yu LL; Wang ZH; Bai H
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):524. PubMed ID: 34384163
    [No Abstract]   [Full Text] [Related]  

  • 45. Posterior Reversible Encephalopathy Syndrome and Cerebral Sinus Thrombosis in a Case of Pediatric B-Cell ALL.
    Fraint E; Miller R; Walter A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e71-e73. PubMed ID: 28060109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate, homocysteine, and seizures.
    Quinn CT; Griener JC; Bottiglieri T; Kamen BA
    J Clin Oncol; 1998 Jan; 16(1):393-4. PubMed ID: 9440774
    [No Abstract]   [Full Text] [Related]  

  • 47. Heterozygous MTHFR A1298C Mutation causing Cerebral Venous Sinus Thrombosis.
    Shah JH; Salagre KD; Sahay RN; Anand A
    J Assoc Physicians India; 2016 Nov; 64(11):76-77. PubMed ID: 27805340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute toxicity of high doses of methotrexate in treatment of ALL in children: a case study].
    Periáñez-Párraga L; Pérez-Rodríguez O; do Pazo-Oubiña F; Crespí-Monjo M
    Farm Hosp; 2009; 33(3):172-3. PubMed ID: 19712601
    [No Abstract]   [Full Text] [Related]  

  • 49. Early diagnosis of leukoencephalopathy of acute lymphocytic leukemia by MRI.
    Ito M; Akiyama Y; Asato R; Kubota M; Kasai Y; Rios E; Mikawa H
    Pediatr Neurol; 1991; 7(6):436-9. PubMed ID: 1797008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlating pathology with the clinical symptoms of methotrexate-induced leukoencephalopathy in a child with relapsed T-cell acute lymphoblastic leukemia.
    Summers RJ; Abramowsky CR; Cooper TM
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e19-22. PubMed ID: 23274378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute leukoencephalopathy possibly induced by phenytoin intoxication in an adult patient with methylenetetrahydrofolate reductase deficiency.
    Arai M; Osaka H
    Epilepsia; 2011 Jul; 52(7):e58-61. PubMed ID: 21480888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superior sagittal sinus thrombosis complicating maintenance treatment for acute lymphoblastic leukemia.
    Nicholson JC; Darmady JM; Kohler JA
    Pediatr Hematol Oncol; 1996; 13(3):287-91. PubMed ID: 8735346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk.
    Juster-Switlyk K; Smith AG; Kovacsovics T; Stephens D; Glenn M; Palmer CA; Quigley EP; Kolb N
    Neurology; 2017 Feb; 88(6):603-604. PubMed ID: 28062724
    [No Abstract]   [Full Text] [Related]  

  • 54. Methotrexate-induced leukoencephalopathy reversed by aminophylline and high-dose folinic acid.
    Jaksic W; Veljkovic D; Pozza C; Lewis I
    Acta Haematol; 2004; 111(4):230-2. PubMed ID: 15153718
    [No Abstract]   [Full Text] [Related]  

  • 55. Methotrexate-induced leukoencephalopathy presenting as acute-onset limb weakness in a child: a case report.
    Pathiraja H; de Abrew G; de Silva L; Fernando S; Randeny S; Mettananda S
    J Med Case Rep; 2024 Sep; 18(1):475. PubMed ID: 39334488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
    Deneux V; Leboucq N; Saumet L; Haouy S; Akbaraly T; Sirvent N
    Arch Pediatr; 2017 Dec; 24(12):1244-1248. PubMed ID: 29146215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia.
    Ozön A; Topaloğlu H; Cila A; Günay M; Cetin M
    Brain Dev; 1994; 16(3):246-8. PubMed ID: 7943613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
    Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
    Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progressive myelopathy mimicking subacute combined degeneration after intrathecal chemotherapy.
    Yi Y; Kang HJ; Shin HY; Kim K
    J Child Neurol; 2015 Feb; 30(2):246-9. PubMed ID: 24659737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies.
    Tsujimoto S; Yanagimachi M; Tanoshima R; Urayama KY; Tanaka F; Aida N; Goto H; Ito S
    Pediatr Blood Cancer; 2016 Nov; 63(11):1983-9. PubMed ID: 27399166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.